Plain-English translation of NCT07512518 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will follow patients who already have or are newly diagnosed with chronic viral infections of the central nervous system (the brain and spinal cord), particularly a serious condition called progressive multifocal leukoencephalopathy (PML). The study will track whether , a type of medication that helps the immune system fight infections, can improve how patients do over time.
Chronic viral infections of the brain are rare and serious, and doctors don't yet have clear evidence about whether this medication helps patients with these conditions. This study aims to gather real-world information about what happens to patients over time and whether the medication makes a meaningful difference.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will either share your existing medical records and past follow-up data if you've already been diagnosed, or you'll be enrolled as a newly diagnosed patient for ongoing tracking. Either way, the research team will monitor your condition over at least one year, collecting information from your doctor visits and any tests performed as part of your regular care. You do not need to take a new medication for this study — researchers are simply observing and learning from what happens to patients like you over time.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
China
Sponsor
Peking Union Medical College Hospital
Enrollment target
~66 participants
Started
February 2023
Primary completion
October 2030
Age range
14 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Siyuan Fan
Peking Union Medical College Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.